Pharmacy Provider Manuals
Welcome to the Pharmacy Corner
The pharmacy program in Delaware is operationally administered through the Delaware Medical Assistance Program (DMAP). Staffing for the Pharmacy Program includes a Pharmacy Director in conjunction with the DXC Pharmacy Team. The objective of the pharmacy program is to ensure that DMAP members have access to appropriate medications while monitoring utilization and cost-effectiveness. The rapid changes in the pharmacy industry and the importance of communicating new information to the pharmacy community are critical to the quality and continuity of care for Delaware citizens. Please click the links on the left to learn more about the pharmacy program.
Tip of the Day
Update: High-Dose Narcotic and Long-Acting and Short-Acting Opioid Criteria
Please note the recent change in DMMA policy regarding the prior authorization criteria for high dose narcotics and long- and short- acting opioids.
The revised PA form can be found on the DMMA website, High-Dose Narcotic and Long-Acting and Short-Acting Opioid Criteria document.
Highlights of the new criteria requirements are below:
- The first fill of a short-acting opioid prescription cannot exceed a 7-day supply
- Prior authorization will be required if the total dose exceeds 90 mg morphine or equivalent (MME) per 24 hours.
- Any prescription dispensed at 90MME or greater should have a prescription for a naloxone rescue preparation.
Opiate Dependence Treatments
Sublocade (buprenorphine extended release injection) is now a Delaware Medicaid preferred product and does not require prior authorization.
Sublocade is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal
buprenorphine-containing product. Sublocade is administered once monthly by a healthcare professional. Please see prescribing information for
additional information on Sublocade.
Current opiate dependence treatments posted on the Preferred Drug Lost (PDL).
Drug Rebate Web Invoicing can be viewed through
Delaware Web Invoicing Information. To apply, please complete both the
Memorandum of Understanding for electronic invoicing
Application for electronic invoicing
forms. Prior versions of this material can be found in the
For questions on Web Invoicing, email: MoveItDocumentTransfer@dxc.com
For any questions related to Drug Rebate, email: DEDrugRebate@dxc.com
W-9 for Drug Rebate
Non-Participating State Manufactures